More
    Guided Solutions - Connecting Talent With Innovation/div>

    Diabetes Reversal Leader Virta Health Raises $133M Series E to Take Type 2 Diabetes Reversal Mainstream

    Led by Tiger Global, the financing values Virta at $2 billion and signals a shift in type 2 diabetes care toward long-term disease reversal...

    LUMICKS Raises $93 Million in Series D Financing

    Backed by global investor syndicate led by new investors Farallon Capital Management and Lauxera Capital Partners along with Softbank Fund 2, funds and accounts...

    Altair Medical secures £2.25m funding for respiratory sensor

    UK-based Altair Medical has secured £2.25 million of pre-Series A funding to further develop its respiratory sensor and real-time monitoring platform. The service uses AI...

    Robotics developer Vicarious Surgical nets BD backing in $1.1B SPAC deal

    Medical technology giant Becton Dickinson & Co., billionaire Bill Gates and Khosla Ventures are among investors backing robotics startup Vicarious Surgical Inc.’s merger with...

    CeQur raises $115M for wearable insulin delivery device

    CeQur announced that it closed an oversubscribed equity financing round with proceeds of $115 million. Lucerne, Switzerland/Marlborough, Mass.-based CeQur said in a news release that it...

    Cardiology robotics platform completes seed round of €4.7M with European Heal Capital

    The company will use the funding to develop remote user interaction for structural heart interventions. US-based developer of the Coral interventional robotics platform, Moray Medical,...

    Memic Innovative Surgery Closes $96M Series D Financing

    Financing led by Peregrine Ventures and Ceros with participation from OurCrowd and Accelmed. Funding primarily supports the commercialisation of Hominis® surgical robot in the United...

    Nucleix Secures $55 Million Funding Led by RA Capital Management and Additional Prominent Life Science Investors to Advance Lung EpiCheck® for Early Detection of...

    Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, has secured $55 million from a syndicate of leading life science...

    LumiraDx to merge with CAHC in $5bn deal

    CA Healthcare Acquisition Corp.— a special purpose acquisition company — announced today that it entered a merger agreement with LumiraDx that will take the company public. LumiraDx’s...

    Latest articles